Nothing Special   »   [go: up one dir, main page]

JPS5498711A - Novel easily decomposable anti-cholinergic, anti-secretic compound and pharmaceutical composition containing the same - Google Patents

Novel easily decomposable anti-cholinergic, anti-secretic compound and pharmaceutical composition containing the same

Info

Publication number
JPS5498711A
JPS5498711A JP15601378A JP15601378A JPS5498711A JP S5498711 A JPS5498711 A JP S5498711A JP 15601378 A JP15601378 A JP 15601378A JP 15601378 A JP15601378 A JP 15601378A JP S5498711 A JPS5498711 A JP S5498711A
Authority
JP
Japan
Prior art keywords
compound
formula
easily decomposable
secretic
cholinergic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP15601378A
Other languages
Japanese (ja)
Inventor
Esu Boodaa Nikorasu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kanebo Ltd
Original Assignee
Kanebo Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kanebo Ltd filed Critical Kanebo Ltd
Publication of JPS5498711A publication Critical patent/JPS5498711A/en
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79—Acids; Esters
    • C07D213/80—Acids; Esters in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C327/00—Thiocarboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/87—Benzo [c] furans; Hydrogenated benzo [c] furans
    • C07D307/90—Benzo [c] furans; Hydrogenated benzo [c] furans with an oxygen atom in position 1 and a nitrogen atom in position 3, or vice versa
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrrole Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

NEW MATERIAL:Anticholinergic compound of formula I (-Y+=formula II, formula III; R2-R4=H, C1-8 chain or alicyclic alyl, C1-8 alkicyclic alkenyl, etc., provided that at least two of the R2-4 are not H; and when two of the R2-4 are H and chain alkyl, the rest is not chain alkyl, etc.; R2-4 may form condensed carbon rings, etc. together with bond α-C; R1 is the group defined in R2-4; X=O, S; Z= halogen, etc.).
EXAMPLE: 1-(d,1-α-Cyclopentylphenylacetoxymethyl)-1-methylpyrrolidinium chloride.
USE: Antisecretories. Anticholinergic nontoxic, and easily decomposable. Little side effects.
PROCESS: A compound formula I is prepared by the reaction of a compound of formula IV, with about equimolar amount of t-amine and unsaturated amine at room temp. or 20W70°C for 24 hr in an inert solvent, e.g. ether.
COPYRIGHT: (C)1979,JPO&Japio
JP15601378A 1977-12-16 1978-12-15 Novel easily decomposable anti-cholinergic, anti-secretic compound and pharmaceutical composition containing the same Pending JPS5498711A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US86121077A 1977-12-16 1977-12-16

Publications (1)

Publication Number Publication Date
JPS5498711A true JPS5498711A (en) 1979-08-03

Family

ID=25335183

Family Applications (1)

Application Number Title Priority Date Filing Date
JP15601378A Pending JPS5498711A (en) 1977-12-16 1978-12-15 Novel easily decomposable anti-cholinergic, anti-secretic compound and pharmaceutical composition containing the same

Country Status (15)

Country Link
JP (1) JPS5498711A (en)
AR (1) AR222478A1 (en)
AT (1) AT366380B (en)
AU (1) AU531835B2 (en)
CA (1) CA1102345A (en)
DE (1) DE2854308A1 (en)
DK (1) DK534178A (en)
ES (1) ES476048A1 (en)
FR (1) FR2422624A1 (en)
GB (1) GB2010270B (en)
IE (1) IE48012B1 (en)
IT (1) IT1101735B (en)
NL (1) NL7812257A (en)
NO (1) NO148776C (en)
SE (1) SE436027B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2015535849A (en) * 2012-10-05 2015-12-17 スファエラ ファーマ ピーティーイー リミテッド Novel compounds, their synthesis and their use

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3045055A1 (en) * 1980-11-29 1982-07-01 Celamerck Gmbh & Co Kg, 6507 Ingelheim HETEROCYCLIC COMPOUNDS
JPS5993075A (en) * 1982-11-18 1984-05-29 Shionogi & Co Ltd Preparation of 1-phthalidyl-5-fluorouracil derivative
US5008111A (en) * 1984-10-11 1991-04-16 Schering Corporation Physiological means of enhancing transdermal delivery of drugs
US4824676A (en) * 1984-10-11 1989-04-25 Schering Corporation Physiological means of enhancing transdermal delivery of drugs
FR2703046B1 (en) * 1993-03-26 1995-05-05 Poudres & Explosifs Ste Nale Process for the preparation of alpha-monohalogenated oxalates and haloglyoxalates and new alpha-monohalogenated oxalates and haloglyoxalates.
AUPN814496A0 (en) 1996-02-19 1996-03-14 Monash University Dermal penetration enhancer
US5962505A (en) * 1998-08-31 1999-10-05 Bobrove; Arthur M. Method for treating hot flashes in humans
US6433003B1 (en) 1999-04-23 2002-08-13 Arthur M. Bobrove Method for treating hyperhidrosis in mammals
AR044134A1 (en) 2003-05-02 2005-08-24 Novartis Ag DERIVATIVES OF QUINUCLIDINE, PREPARATION METHOD AND PHARMACEUTICAL COMPOSITIONS.
MX2007015255A (en) 2005-06-03 2008-02-22 Acrux Dds Pty Ltd Method and composition for transdermal drug delivery.
EA200801591A1 (en) * 2005-12-30 2008-12-30 Рэнбакси Лабораториз Лимитед MUSCARINE RECEPTOR ANTAGONISTS
EA201000747A1 (en) 2007-11-02 2010-10-29 АКРУКС ДиДиЭс ПиТиУай ЭлТиДи SYSTEM AND METHOD OF TRANSDERMAL DELIVERY AND METHOD OF OBTAINING TRANSDERMAL DELIVERY SYSTEM
DE102013013397A1 (en) 2013-08-13 2015-03-12 Epinamics Gmbh Aerosol dispenser for transdermal pharmaceutical compositions
CN110041264A (en) * 2019-04-11 2019-07-23 贺州学院 A kind of adamantyl glyoxaline ion liquid and preparation method thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL101555C (en) * 1955-03-19
BE798253A (en) * 1973-04-16 1973-10-16 Bekaert Sa Nv SEATING
US3998815A (en) * 1974-06-24 1976-12-21 Interx Research Corporation 1-hydrocarbonoyloxymethyl-3-carbamoyl or 3-carboethoxy-pyridinium salts

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2015535849A (en) * 2012-10-05 2015-12-17 スファエラ ファーマ ピーティーイー リミテッド Novel compounds, their synthesis and their use

Also Published As

Publication number Publication date
AT366380B (en) 1982-04-13
IE48012B1 (en) 1984-09-05
GB2010270A (en) 1979-06-27
CA1102345A (en) 1981-06-02
IE782499L (en) 1979-06-16
NO784229L (en) 1979-06-19
IT1101735B (en) 1985-10-07
SE7812911L (en) 1979-06-17
NL7812257A (en) 1979-06-19
FR2422624B1 (en) 1983-10-14
FR2422624A1 (en) 1979-11-09
IT7830735A0 (en) 1978-12-12
DE2854308A1 (en) 1979-06-21
AU4264678A (en) 1979-06-21
AR222478A1 (en) 1981-05-29
ES476048A1 (en) 1979-11-01
DK534178A (en) 1979-06-17
NO148776C (en) 1983-12-14
ATA901478A (en) 1981-08-15
GB2010270B (en) 1982-10-20
AU531835B2 (en) 1983-09-08
SE436027B (en) 1984-11-05
NO148776B (en) 1983-09-05

Similar Documents

Publication Publication Date Title
JPS5498711A (en) Novel easily decomposable anti-cholinergic, anti-secretic compound and pharmaceutical composition containing the same
JPS55102583A (en) 20-acyloxy-20-demethylmaytansinoid compound
JPS54117486A (en) 2-phenoxypyrimidine derivative
ZA826755B (en) Substituted phenylsulfonylurea derivatives,a process for their preparation and their use as herbicides,and new intermediate products for their preparation
ES479832A1 (en) Mercaptoacylamino acids
ES2104688T3 (en) A PROCEDURE FOR THE PREPARATION OF A TIO-3-CEFEM 3-SUBSTITUTED COMPOUND.
JPS557201A (en) Derivative of tetrahydrothiopyrano(2,3-b)indole
JPS5697268A (en) Lower alkanoic acid derivative, salt and preparation thereof and preventing agent and remedy for diabetic complication containing the same as active constituent
JPS5653664A (en) Preparation of delta2-1,2,4-triazolin-5-ones
JPS5634674A (en) Isoxazolin-3-one derivative
JPS5515457A (en) Dithiocarbamic acid derivative
JPS5753480A (en) Tetrahydro-1-alkylthiophenium derivative
JPS5551065A (en) Aminopyrrole derivative
JPS5583766A (en) Isoxazolin-3-one derivative
JPS57144270A (en) Phenothiazine derivative, its preparation, and analgesic and antiphlogistic agent containing said derivative as active component
JPS5748932A (en) Gamma,delta-unsaturated alpha,alpha-dichlorocarbonyl compound and its preparation
JPS6447784A (en) Bezothiazine derivative, production thereof and herbicide containing said derivative as active ingredient
JPS55115889A (en) 6-carbamoylthiazolo 3,2-a pyrimidine derivative and its preparation
JPS54128583A (en) Thiosemicarbazone derivative
JPS55104274A (en) Isoxazolin-3-one derivative and its preparation
JPS5452075A (en) Isoxazolium salt and its preparation
JPS5711975A (en) Aminophenyltetrazole derivative and salt thereof
JPS5551068A (en) Novel hydantoin derivative, and antiphlogistic analgesic agent containing the same
JPS52113970A (en) Thiadiazoline-type organic phosphates, their preparation, and insectic ide or miticide containing the same
JPS54145615A (en) Derivative of (1,3)-beta-d-glucane, its use and preparation